Login / Signup
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.
Deepak Jakhar
Ishmeet Kaur
Published in:
Nature medicine (2020)
Keyphrases
</>
systemic lupus erythematosus
coronavirus disease
sars cov
disease activity
respiratory syndrome coronavirus
rheumatoid arthritis
plasmodium falciparum
climate change